Showing results (1-10 of 546) with videos related to
Sort By:
Pageof 55
Frontiers in Psychiatry|December 11, 2013
Relationship between Glutamate Dysfunction and Symptoms and Cognitive Function in PsychosisKate Merritt, Philip McGuire, Alice EgertonFrontiers in Psychiatry|May 16, 2017
Effects of Antipsychotic Administration on Brain Glutamate in Schizophrenia: A Systematic Review of Longitudinal <sup>1</sup>H-MRS StudiesAlice Egerton, Akarmi Bhachu, Kate Merritt, et al.JAMA Psychiatry|June 16, 2016
Nature of Glutamate Alterations in Schizophrenia: A Meta-analysis of Proton Magnetic Resonance Spectroscopy StudiesKate Merritt, Alice Egerton, Matthew J Kempton, et al.Neuroimage|December 26, 2009
The test-retest reliability of 18F-DOPA PET in assessing striatal and extrastriatal presynaptic dopaminergic functionAlice Egerton, Arsime Demjaha, Philip McGuire, et al.Schizophrenia Research|October 19, 2020
Glutamate in schizophrenia: Neurodevelopmental perspectives and drug developmentAlice Egerton, Anthony A Grace, James Stone, et al.Psychopharmacology|September 6, 2019
The potential of <sup>1</sup>H-MRS in CNS drug developmentAlice EgertonNPJ Schizophrenia|August 3, 2019
Remission from antipsychotic treatment in first episode psychosis related to longitudinal changes in brain glutamateKate Merritt, Rocio Perez-Iglesias, Kyra-Verena Sendt, et al.Journal of Psychopharmacology (Oxford, England)|May 22, 2020
Glyceryl trinitrate in first-episode psychosis unmedicated with antipsychotics: A randomised controlled pilot studyKate Merritt, Ana Catalan, Samuel Cowley, et al.The American Journal of Psychiatry|December 20, 2015
Resting Hyperperfusion of the Hippocampus, Midbrain, and Basal Ganglia in People at High Risk for PsychosisPaul Allen, Christopher A Chaddock, Alice Egerton, et al.The American Journal of Psychiatry|July 20, 2011
Dopamine synthesis capacity before onset of psychosis: a prospective [18F]-DOPA PET imaging studyOliver D Howes, Subrata K Bose, Federico Turkheimer, et al.Pageof 55